Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

RVVTF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.01M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revive Therapeutics Ltd.Revive Therapeutics Ltd.-12.5-25%--
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.01 Million
Enterprise Value$2.99 Million
Earnings per Share$0
Beta-1.94
Outstanding Shares435,676,173

Return

Return on Equity25.48%ROE
Return on Assets-361.62%
Return on Invested Capital25.71%

Valuation & Multiples

P/E Ratio-12.5P/E Ratio
PEG12.5PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.95
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Revive Therapeutics Ltd.

2 employees
CEO: Michael Frank

Revive Therapeutics Ltd., a life sciences firm, specializes in the research and development of treatments for rare disorders and infectious diseases. The company’s pharmaceutical pipeline features a cannabinoid portfolio focused on rare ...

Questions & Answers